制移动信息对信仰,意图,坚持和喘控制的影响:一项随机试验
Ruth Jeminiwa1, Kimberly B Garza2, Chiahung Chou2
1Department of Pharmacy Practice, Thomas Jefferson University, 901 Walnut Street, Philadelphia, PA 19107, USA.
Pharmacy (Basel, Switzerland)
|January 22, 2024
概括
框架式移动信息改善了年轻成年人的喘控制和药物坚持意图. 这项研究强调了数字健康干预措施在年轻人中管理喘等慢性疾病的潜力.
科学领域:
- 数字健康干预措施 数字健康干预措施
- 行为科学 行为科学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 在年轻人中,喘管理需要始终坚持吸入性皮质类固醇 (ICS).
- 移动消息干预提供了一个可扩展的方法来支持药物坚持.
- 框架效应 (收益与损失) 可能会影响消息的有效性.
研究的目的:
- 评估收益框架与损失框架移动信息对年轻成年人ICS信念,意图,坚持和喘控制的影响.
- 评估年轻成人喘人口中使用移动信息的参与率.
- 为了比较不同信息框架策略的有效性.
主要方法:
- 一个随机对照试验,涉及43名大学生 (18-29岁) 在ICS上患有喘.
- 参与者每周三次收到八周的收益或损失框架的短信.
- 结果 (信念,意图,坚持,喘控制) 在基线,第4周和第8周使用混合设计ANOVA测量.
主要成果:
- 观察到高信息参与度 (85.9%) 和100%的参与者保留率.
- 参与者服用药物和控制喘的意图有显著的改善.
- 在收益框架和损失框架的消息组之间没有发现结果的显著差异.
结论:
- 框架式移动信息可以有效地提高年轻人对药物坚持的意图,并改善喘控制.
- 具体的框架 (收益与损失) 对测量的结果没有产生差异性影响.
- 移动卫生干预措施对支持年轻成年人的慢性疾病管理有希望.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Framing Effects
7.4K
Information is everywhere and its presentation—such as how and when items are presented—can impact our perceptions and decisions surrounding the info. This broad concept umbrellas framing effects—influences that occur due to the way information is framed in its appearance, whether it’s purely the order or the specific wording of a message. Let’s take a look at numerous ways in which two versions of something can objectively say the same thing, yet we respond in...
7.4K
Antiasthma Drugs: β2-Adrenoceptor Agonists
267
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
267
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
299
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
299
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


